|
Index of reports
> Cases resulting in disability (19)
> Cases with Blood Creatinine Increased (6)
Below is the selection of adverse event reports related to Diovan (Valsartan) that includes cases resulting in disability where reactions include blood creatinine increased.
Adverse event in 10 year old male receiving Diovan (Valsartan)
Reported by a individual with unspecified qualification from Japan on 2007-10-29
Patient: 10 year old male, weighing 60.0 kg (132.0 pounds)
Adverse reactions / side effects: Blood Urea Increased, Headache, Superior Sagittal Sinus Thrombosis, Nephrotic Syndrome, Convulsion, Cerebral Infarction, Dehydration, Proteinuria, Oliguria, Oedema, Blood Creatinine Increased, Acute Prerenal Failure, Anuria, Influenza
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Acecol
Dosage: 2 mg/d
Administration route: Oral
Indication: Nephrotic Syndrome
End date: 2007-03-01
Bredinin
Dosage: 150 mg/d
Administration route: Oral
Indication: Nephrotic Syndrome
Diovan
Dosage: 80 mg/d
Administration route: Oral
Indication: Nephrotic Syndrome
End date: 2007-03-01
Neoral
Dosage: 140 mg/d
Administration route: Oral
Indication: Nephrotic Syndrome
End date: 2007-03-19
Predonine
Dosage: 40 mg/d
Administration route: Oral
Indication: Nephrotic Syndrome
Other drugs received by patient: Lipitor; Zyloric
Adverse event in 10 year old male receiving Diovan (Valsartan)
Reported by a individual with unspecified qualification from Japan on 2007-10-29
Patient: 10 year old male, weighing 60.0 kg (132.0 pounds)
Adverse reactions / side effects: Blood Urea Increased, Headache, Superior Sagittal Sinus Thrombosis, Nephrotic Syndrome, Convulsion, Cerebral Infarction, Dehydration, Proteinuria, Oliguria, Oedema, Blood Creatinine Increased, Acute Prerenal Failure, Anuria, Influenza
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Acecol
Dosage: 2 mg/d
Administration route: Oral
Indication: Nephrotic Syndrome
End date: 2007-03-01
Bredinin
Dosage: 150 mg/d
Administration route: Oral
Indication: Nephrotic Syndrome
Diovan
Dosage: 80 mg/d
Administration route: Oral
Indication: Nephrotic Syndrome
End date: 2007-03-01
Neoral
Dosage: 140 mg/d
Administration route: Oral
Indication: Nephrotic Syndrome
End date: 2007-03-19
Predonine
Dosage: 40 mg/d
Administration route: Oral
Indication: Nephrotic Syndrome
Other drugs received by patient: Lipitor; Zyloric
Adverse event in 68 year old male receiving Diovan (Valsartan)
Reported by a pharmacist from Japan on 2007-07-27
Patient: 68 year old male, weighing 48.0 kg (105.6 pounds)
Adverse reactions / side effects: Blood Creatine Phosphokinase Increased, Intubation, Blood Albumin Decreased, X-RAY Abnormal, Haematocrit Decreased, C-Reactive Protein Increased, Gamma-Glutamyltransferase Increased, RED Blood Cell Count Decreased, Interstitial Lung Disease, Blood Sodium Increased, Blood Creatinine Increased, Oxygen Saturation Decreased, White Blood Cell Count Increased, Blood Urea Increased, Blood Lactate Dehydrogenase Increased, Alanine Aminotransferase Increased, Blood Chloride Increased, Life Support, Protein Total Decreased, Albumin Globulin Ratio Decreased, Computerised Tomogram Abnormal, Mean Cell Volume Abnormal, Haemoglobin Decreased, Aspartate Aminotransferase Increased, Cell Marker, Platelet Count Decreased
Adverse event resulted in: disablity
Suspect drug(s):
Amiodarone HCL
Dosage: 400 mg/day
Administration route: Oral
Start date: 2007-04-24
End date: 2007-06-04
Diovan
Dosage: 80 mg, bid
Administration route: Oral
Indication: Hypertension
Start date: 2007-05-16
End date: 2007-05-16
Diovan
Dosage: 160 mg, bid
Administration route: Oral
Start date: 2007-05-17
End date: 2007-06-07
Adverse event in 68 year old male receiving Diovan (Valsartan)
Reported by a pharmacist from Japan on 2007-07-26
Patient: 68 year old male, weighing 48.0 kg (105.6 pounds)
Adverse reactions / side effects: Blood Creatine Phosphokinase Increased, Intubation, Blood Albumin Decreased, X-RAY Abnormal, Blood Albumin Increased, Haematocrit Decreased, C-Reactive Protein Increased, Gamma-Glutamyltransferase Increased, Interstitial Lung Disease, RED Blood Cell Count Decreased, Blood Sodium Increased, Blood Creatinine Increased, Oxygen Saturation Decreased, White Blood Cell Count Increased, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Blood Chloride Increased, Life Support, Protein Total Decreased, Computerised Tomogram Abnormal, Mean Cell Volume Abnormal, Haemoglobin Decreased, Aspartate Aminotransferase Increased, Cell Marker, Platelet Count Decreased
Adverse event resulted in: disablity
Suspect drug(s):
Amiodarone HCL
Dosage: 400 mg/day
Administration route: Oral
Start date: 2007-04-24
End date: 2007-06-04
Diovan
Dosage: 80 mg, bid
Administration route: Oral
Indication: Hypertension
Start date: 2007-05-16
End date: 2007-05-16
Diovan
Dosage: 160 mg, bid
Administration route: Oral
Start date: 2007-05-17
End date: 2007-06-07
Adverse event in 68 year old male receiving Diovan (Valsartan)
Reported by a pharmacist from Japan on 2007-07-06
Patient: 68 year old male, weighing 48.0 kg (105.6 pounds)
Adverse reactions / side effects: Blood Creatine Phosphokinase Increased, Intubation, Blood Albumin Decreased, X-RAY Abnormal, Blood Albumin Increased, Haematocrit Decreased, C-Reactive Protein Increased, Gamma-Glutamyltransferase Increased, Interstitial Lung Disease, RED Blood Cell Count Decreased, Blood Sodium Increased, Blood Creatinine Increased, Oxygen Saturation Decreased, White Blood Cell Count Increased, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Blood Chloride Increased, Life Support, Protein Total Decreased, Computerised Tomogram Abnormal, Mean Cell Volume Abnormal, Haemoglobin Decreased, Aspartate Aminotransferase Increased, Cell Marker, Platelet Count Decreased
Adverse event resulted in: disablity
Suspect drug(s):
Amiodarone HCL
Dosage: unk, unk
Administration route: Oral
Start date: 2007-04-24
End date: 2007-06-04
Diovan
Dosage: 80 mg, bid
Administration route: Oral
Indication: Hypertension
Start date: 2007-05-16
End date: 2007-05-16
Diovan
Dosage: 160 mg, bid
Administration route: Oral
Start date: 2007-05-17
End date: 2007-06-07
Adverse event in 68 year old male receiving Diovan (Valsartan)
Reported by a pharmacist from Japan on 2007-07-06
Patient: 68 year old male, weighing 48.0 kg (105.6 pounds)
Adverse reactions / side effects: Blood Creatine Phosphokinase Increased, Intubation, Blood Albumin Decreased, X-RAY Abnormal, Blood Albumin Increased, Haematocrit Decreased, C-Reactive Protein Increased, Gamma-Glutamyltransferase Increased, Interstitial Lung Disease, RED Blood Cell Count Decreased, Blood Sodium Increased, Blood Creatinine Increased, Oxygen Saturation Decreased, White Blood Cell Count Increased, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Blood Chloride Increased, Life Support, Protein Total Decreased, Computerised Tomogram Abnormal, Mean Cell Volume Abnormal, Haemoglobin Decreased, Aspartate Aminotransferase Increased, Cell Marker, Platelet Count Decreased
Adverse event resulted in: disablity
Suspect drug(s):
Amiodarone HCL
Dosage: unk, unk
Administration route: Oral
Start date: 2007-04-24
End date: 2007-06-04
Diovan
Dosage: 80 mg, bid
Administration route: Oral
Indication: Hypertension
Start date: 2007-05-16
End date: 2007-05-16
Diovan
Dosage: 160 mg, bid
Administration route: Oral
Start date: 2007-05-17
End date: 2007-06-07
|
